A “groundbreaking” cystic fibrosis therapy could profoundly improve patients’ quality of life, say doctors.
Patients often die before their 40s as mucus clogs and damages their lungs and leaves them prone to infection.
A major trial on 1,108 patients, in the New England Journal of Medicine, showed a combination of drugs could bypass the genetic errors that cause the disease and may increase life expectancy.
The Cystic Fibrosis Trust said it could “improve the lives of many”.